Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sandler O'Neill + Partners was a prominent American investment banking firm that specialized in providing strategic advisory and capital markets services to the financial services industry. Founded in 1988, the firm built a reputation as a premier advisor for mergers and acquisitions, capital raising, and equity research, particularly for mid-sized banks and insurance companies. The firm was notably impacted by the September 11 attacks, losing 66 employees, but successfully rebuilt its operations to remain a leader in the Financial Institutions Group (FIG) sector. In January 2020, the company was acquired by Piper Jaffray in a deal valued at approximately $485 million, resulting in the formation of Piper Sandler Companies. While Sandler O'Neill was not a biotechnology company, its successor, Piper Sandler, maintains a significant presence in healthcare and life sciences investment banking.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Sandler O'Neill + Partners.